Mutations of thePTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations

This publication has 19 references indexed in Scilit:

• Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies
  Genes, Chromosomes and Cancer, 2006
• Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations
  Leukemia, 2006
• Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia
  Leukemia, 2005
• The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease
  Blood, 2005
• PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group
  Leukemia, 2004
• Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation
  Blood, 2004
• Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
  Blood, 2004
• GENETICS OF MYELOID LEUKEMIAS
  Annual Review of Genomics and Human Genetics, 2002
• Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML
  Leukemia, 2002
• Noonan's Syndrome in Association with Acute Leukemia
  Pediatric Hematology and Oncology, 1995